Camurus AB - Asset Resilience Ratio

Latest as of December 2025: 78.61%

Camurus AB (CAMX) has an Asset Resilience Ratio of 78.61% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Camurus AB's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Skr3.73 Billion

≈ $400.97 Million USD Cash + Short-term Investments

Total Assets

Skr4.74 Billion

≈ $510.10 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Camurus AB's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Camurus AB to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Camurus AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Camurus AB stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr3.73 Billion	78.61%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr3.73 Billion	78.61%

Asset Resilience Insights

Very High Liquidity: Camurus AB maintains exceptional liquid asset reserves at 78.61% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Camurus AB Industry Peers by Asset Resilience Ratio

Compare Camurus AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Camurus AB (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Camurus AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	78.61%	Skr3.73 Billion ≈ $400.97 Million	Skr4.74 Billion ≈ $510.10 Million	+35.29pp
2022-12-31	43.32%	Skr565.54 Million ≈ $60.86 Million	Skr1.31 Billion ≈ $140.49 Million	+5.28pp
2021-12-31	38.04%	Skr411.57 Million ≈ $44.29 Million	Skr1.08 Billion ≈ $116.43 Million	-6.19pp
2020-12-31	44.23%	Skr461.79 Million ≈ $49.70 Million	Skr1.04 Billion ≈ $112.36 Million	-2.24pp
2019-12-31	46.47%	Skr358.74 Million ≈ $38.61 Million	Skr772.05 Million ≈ $83.08 Million	+9.62pp
2018-12-31	36.84%	Skr134.38 Million ≈ $14.46 Million	Skr364.72 Million ≈ $39.25 Million	--

pp = percentage points

About Camurus AB

ST:CAMX Sweden Biotechnology

Market Cap

$3.33 Billion

Skr30.95 Billion SEK

Market Cap Rank

#4722 Global

#59 in Sweden

Share Price

Skr519.00

Change (1 day)

-2.63%

52-Week Range

Skr437.40 - Skr733.50

All Time High

Skr733.50